Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis

BACKGROUND: Radiotherapy is the mainstay of brain metastasis (BM) management. Radiation necrosis (RN) is a serious complication of radiotherapy. Bevacizumab (BV), an anti-vascular endothelial growth factor monoclonal antibody, has been increasingly used for RN treatment. We systematically reviewed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad, Zhao, Zhihong, Arooj, Sumbal, Liao, Guixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885379/
https://www.ncbi.nlm.nih.gov/pubmed/33593308
http://dx.doi.org/10.1186/s12885-021-07889-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885379/
https://www.ncbi.nlm.nih.gov/pubmed/33593308
http://dx.doi.org/10.1186/s12885-021-07889-3

Ejemplares similares